Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Signaling Pathways in T-cell acute lymphoblastic leukemia initiating cells
Alberto M. Martelli, Annalisa Lonetti, Francesca Buontempo, et al.
Advances in Biological Regulation (2014) Vol. 56, pp. 6-21
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

PTEN: Multiple Functions in Human Malignant Tumors
Michèle Milella, Italia Falcone, Fabiana Conciatori, et al.
Frontiers in Oncology (2015) Vol. 5
Open Access | Times Cited: 420
The PI3K/Akt/PTEN/mTOR Pathway: A Fruitful Target for Inducing Cell Death in Rheumatoid Arthritis?
Charles J. Malemud
Future Medicinal Chemistry (2015) Vol. 7, Iss. 9, pp. 1137-1147
Closed Access | Times Cited: 158
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer
James A. McCubrey, Dariusz Rakus, Agnieszka Gizak, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2016) Vol. 1863, Iss. 12, pp. 2942-2976
Open Access | Times Cited: 140
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting
Francesca Chiarini, Annalisa Lonetti, Camilla Evangelisti, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2015) Vol. 1863, Iss. 3, pp. 449-463
Open Access | Times Cited: 135
PLC and PI3K/Akt/mTOR signalling in disease and cancer
Marie Follo, Lucia Manzoli, Alessandro Poli, et al.
Advances in Biological Regulation (2014) Vol. 57, pp. 10-16
Closed Access | Times Cited: 121
The therapeutic potential of mTOR inhibitors in breast cancer
Linda S. Steelman, Alberto M. Martelli, Lucio Cocco, et al.
British Journal of Clinical Pharmacology (2016) Vol. 82, Iss. 5, pp. 1189-1212
Open Access | Times Cited: 112
Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis
James A. McCubrey, Stephen L. Abrams, Timothy L. Fitzgerald, et al.
Advances in Biological Regulation (2014) Vol. 57, pp. 75-101
Closed Access | Times Cited: 109
Novel biological insights in T-cell acute lymphoblastic leukemia
Kaat Durinck, Steven Goossens, Sofie Peirs, et al.
Experimental Hematology (2015) Vol. 43, Iss. 8, pp. 625-639
Open Access | Times Cited: 104
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy
Saverio Candido, Stephen L. Abrams, Linda S. Steelman, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2015) Vol. 1863, Iss. 3, pp. 438-448
Closed Access | Times Cited: 91
Strategies for Isolating and Enriching Cancer Stem Cells: Well Begun Is Half Done
Jiang‐Jie Duan, Wen Qiu, Senlin Xu, et al.
Stem Cells and Development (2013) Vol. 22, Iss. 16, pp. 2221-2239
Open Access | Times Cited: 87
Class I PI 3-kinases: Function and evolution
Nisha Kriplani, Miguel A. Hermida, Euan R. Brown, et al.
Advances in Biological Regulation (2015) Vol. 59, pp. 53-64
Closed Access | Times Cited: 74
Targeting mTOR in Acute Lymphoblastic Leukemia
Carolina Simioni, Alberto M. Martelli, Giorgio Zauli, et al.
Cells (2019) Vol. 8, Iss. 2, pp. 190-190
Open Access | Times Cited: 57
Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL
Sujan Piya, Ya‐Ling Yang, Seemana Bhattacharya, et al.
Leukemia (2022) Vol. 36, Iss. 5, pp. 1261-1273
Open Access | Times Cited: 28
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells
Micol Silic‐Benussi, Evgenyia Sharova, Francesco Ciccarese, et al.
Redox Biology (2022) Vol. 51, pp. 102268-102268
Open Access | Times Cited: 28
PTEN and leukemia stem cells
Rita Fragoso, João T. Barata
Advances in Biological Regulation (2014) Vol. 56, pp. 22-29
Closed Access | Times Cited: 38
Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cells
William H. Chappell, Stephen L. Abrams, Kvin Lertpiriyapong, et al.
Advances in Biological Regulation (2015) Vol. 60, pp. 64-87
Closed Access | Times Cited: 34
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia
Alice Cani, Carolina Simioni, Alberto M. Martelli, et al.
Oncotarget (2015) Vol. 6, Iss. 9, pp. 6597-6610
Open Access | Times Cited: 28
An integrated transcriptome analysis in T‐cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression
Z. Haider, Pär Larsson, Mattias Landfors, et al.
Cancer Medicine (2018) Vol. 8, Iss. 1, pp. 311-324
Open Access | Times Cited: 24
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia
Carolina Simioni, Simona Ultimo, Alberto M. Martelli, et al.
Oncotarget (2016) Vol. 7, Iss. 48, pp. 79842-79853
Open Access | Times Cited: 23
Differential Co-expression and Regulatory Network Analysis Uncover the Relapse Factor and Mechanism of T Cell Acute Leukemia
Mei Luo, Qiong Zhang, Mengxuan Xia, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 12, pp. 184-194
Open Access | Times Cited: 21
Upregulation of leukemia-induced non-coding activator RNA (LUNAR1) predicts poor outcome in pediatric T-acute lymphoblastic leukemia
Nashwa El‐Khazragy, Mahfouz A. Abdel Aziz, Manar Hesham, et al.
Immunobiology (2021) Vol. 226, Iss. 6, pp. 152149-152149
Closed Access | Times Cited: 16
Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells
Jessika Bertacchini, Chiara Frasson, Francesca Chiarini, et al.
Advances in Biological Regulation (2018) Vol. 68, pp. 2-9
Closed Access | Times Cited: 20
Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) drives migration and progression of T-cell acute lymphoblastic leukemia in vitro and in vivo
Wei Min, M. G. Haney, Dylan R. Rivas, et al.
Oncogenesis (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Either IL-7 activation of JAK-STAT or BEZ inhibition of PI3K-AKT-mTOR pathways dominates the single-cell phosphosignature of <i>ex vivo</i> treated pediatric T-cell acute lymphoblastic leukemia cells
Daniela Kužílková, Cristina Bugarin, Kateřina Rejlová, et al.
Haematologica (2021) Vol. 107, Iss. 6, pp. 1293-1310
Open Access | Times Cited: 13
Overexpression of CD59 inhibits apoptosis of T-acute lymphoblastic leukemia via AKT/Notch1 signaling pathway
Yanfei Jia, Yan Qi, Yunshan Wang, et al.
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top